Plumbline Life Sciences, Inc. (XKON:222670)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,600.00
+150.00 (2.33%)
At close: May 13, 2025, 3:30 PM KST
6.62%
Market Cap 22.00B
Revenue n/a
Net Income n/a
Shares Out 3.33M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,527
Average Volume 2,931
Open 6,590.00
Previous Close 6,450.00
Day's Range 6,540.00 - 6,600.00
52-Week Range 3,360.00 - 7,950.00
Beta 0.47
RSI 68.93
Earnings Date n/a

About Plumbline Life Sciences

Plumbline Life Sciences, Inc. engages in the development and sale of DNA medicines for animals. Its products include LifeTide SW5, a pig immune-modulator; PLS-ASF, a swine fever DNA vaccine; PLS-FMD; PLS-B3000, a dairy cattle DNA therapy; PLS-IF1000, a FMD vaccine; PLS-H1000, a horse laminitis therapy; PLS-D5000, a dog DNA cancer immunotherapy; PLS-D1000 for age related immune deficiency in senior dogs; and PLS-C2000 for age related immune deficiency in senior cats. Plumbline Life Sciences, Inc. was founded in 2014 and is headquartered in Seoul... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2014
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 222670
Full Company Profile

News

There is no news available yet.